search
Back to results

Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health

Primary Purpose

Cardiovascular Diseases, Kidney Diseases

Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Sponsored by
Khyber Medical University Peshawar
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiovascular Diseases focused on measuring TBARs, TAC, pCS, Barley, Beta-glucan, E-selectin, NO

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy individuals of age 18 years or older
  • BMI ranged between 18.5 and 24.9

Exclusion Criteria:

  • Celiac disease, Cancer, Diabetes , cardiovascular diseases
  • Gastro intestinal tract disease
  • Pregnant women
  • Use of pre-, pro- or antibiotics 15 days before the enrollment into the study
  • Food allergy to food used in the trial

Sites / Locations

  • Khyber Medical University, Peshawar

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Whole wheat bread

Barley supplemented wheat bread

Arm Description

Whole wheat bread will be used as control bread.

Barley supplemented wheat bread (50% substitution) will be used as experimental bread.

Outcomes

Primary Outcome Measures

Change in Serum Thiobarbituric acid reactive substances (TBARs) from baseline to 4 weeks
Change in Serum Total antioxidant capacity (TAC) from baseline to 4 weeks
Change in Serum Nitric oxide from baseline to 4 weeks
change in Serum E-selectin from baseline to 4 weeks
Change in Serum P-cresyl sulfate from baseline to 4 weeks
Change in Serum Indoxyl sulfate from baseline to 4 weeks

Secondary Outcome Measures

Full Information

First Posted
February 28, 2022
Last Updated
April 6, 2023
Sponsor
Khyber Medical University Peshawar
search

1. Study Identification

Unique Protocol Identification Number
NCT05312788
Brief Title
Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health
Official Title
Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
May 4, 2022 (Actual)
Primary Completion Date
August 10, 2022 (Actual)
Study Completion Date
August 10, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Khyber Medical University Peshawar

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The disruption of colonic microbiota has been linked to a number of diseases, mainly cardiovascular and kidney diseases. One possible means to improve the microbiota is to increase dietary fiber intake as the intake of dietary fiber shifts the fermentation from proteolytic saccharolytic fermentation. Beta-glucans are soluble dietary fibers mainly found in oats and barley. Results from previous studies suggest that the consumption of barley reduces the risk of cardiovascular and kidney diseases. Therefore, this study will explore the effect of barley beta-glucans on markers of Cardiovascular and Renal health.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases, Kidney Diseases
Keywords
TBARs, TAC, pCS, Barley, Beta-glucan, E-selectin, NO

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Whole wheat bread
Arm Type
Placebo Comparator
Arm Description
Whole wheat bread will be used as control bread.
Arm Title
Barley supplemented wheat bread
Arm Type
Experimental
Arm Description
Barley supplemented wheat bread (50% substitution) will be used as experimental bread.
Intervention Type
Other
Intervention Name(s)
Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Intervention Description
Intervention will involve intake of 50% barley substituted wheat bread.
Primary Outcome Measure Information:
Title
Change in Serum Thiobarbituric acid reactive substances (TBARs) from baseline to 4 weeks
Time Frame
Baseline and after 4 weeks
Title
Change in Serum Total antioxidant capacity (TAC) from baseline to 4 weeks
Time Frame
Baseline and after 4 weeks
Title
Change in Serum Nitric oxide from baseline to 4 weeks
Time Frame
Baseline and after 4 weeks
Title
change in Serum E-selectin from baseline to 4 weeks
Time Frame
Baseline and after 4 weeks
Title
Change in Serum P-cresyl sulfate from baseline to 4 weeks
Time Frame
Baseline and after 4 weeks
Title
Change in Serum Indoxyl sulfate from baseline to 4 weeks
Time Frame
Baseline and after 4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy individuals of age 18 years or older BMI ranged between 18.5 and 24.9 Exclusion Criteria: Celiac disease, Cancer, Diabetes , cardiovascular diseases Gastro intestinal tract disease Pregnant women Use of pre-, pro- or antibiotics 15 days before the enrollment into the study Food allergy to food used in the trial
Facility Information:
Facility Name
Khyber Medical University, Peshawar
City
Peshawar
State/Province
KPK
ZIP/Postal Code
25000
Country
Pakistan

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28107445
Citation
Cosola C, De Angelis M, Rocchetti MT, Montemurno E, Maranzano V, Dalfino G, Manno C, Zito A, Gesualdo M, Ciccone MM, Gobbetti M, Gesualdo L. Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals. PLoS One. 2017 Jan 20;12(1):e0169635. doi: 10.1371/journal.pone.0169635. eCollection 2017.
Results Reference
background
PubMed Identifier
25147155
Citation
Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1603-10. doi: 10.2215/CJN.00490114. Epub 2014 Aug 21.
Results Reference
background
PubMed Identifier
26236103
Citation
Bacchetti T, Tullii D, Masciangelo S, Gesuita R, Skrami E, Bruge F, Silvestri S, Orlando P, Tiano L, Ferretti G. Effect of a barley-vegetable soup on plasma carotenoids and biomarkers of cardiovascular disease. J Clin Biochem Nutr. 2015 Jul;57(1):66-73. doi: 10.3164/jcbn.15-11. Epub 2015 Jun 5.
Results Reference
background
PubMed Identifier
31590437
Citation
Gaesser GA, Rodriguez J, Patrie JT, Whisner CM, Angadi SS. Effects of Glycemic Index and Cereal Fiber on Postprandial Endothelial Function, Glycemia, and Insulinemia in Healthy Adults. Nutrients. 2019 Oct 6;11(10):2387. doi: 10.3390/nu11102387.
Results Reference
background

Learn more about this trial

Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health

We'll reach out to this number within 24 hrs